DelAversano Robert J
- SEC CIK
- 0001728262
No open-market purchases or sales filed in the past year.
Current role at each company
- GRCE Grace Therapeutics, Inc.Principal Financial Officeras of Sep 1, 2026
- ONCS Oncosec Medical IncVP, Financeas of Feb 9, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists DelAversano Robert J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ONCS Oncosec Medical Inc
VP, Finance7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2023 (view filing) | Feb 9 | Same day | DelAversano Robert JVP, Finance | SSale | −40 | $1.37 | −$54.8 | −3.8%1.01K after | |
| Nov 4, 2022 (view filing)8:21 PM ET | Nov 4 | Same day | DelAversano Robert JVP, Finance | SSale | −283 | $0.37 | −$104.71 | −1.2%23.0K after | |
| Aug 5, 2022 (view filing) | Aug 5 | Same day | DelAversano Robert JVP, Finance | SSale | −284 | $0.71 | −$201.64 | −1.2%23.3K after | |
| May 6, 2022 (view filing) | May 6 | Same day | DelAversano Robert JVP, Finance | SSale | −274 | $0.83 | −$227.42 | −1.2%23.5K after | |
| Feb 11, 2022 (view filing) | Feb 9 | 2 days | DelAversano Robert JVP, Finance | SSale | −409 | $0.88 | −$359.92 | −1.7%23.8K after | |
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | DelAversano Robert JVP, Finance | SSale | −343 | $1.75 | −$600.25 | −1.4%24.2K after | |
| Aug 3, 2021 (view filing) | Aug 2 | 1 day | DelAversano Robert JVP, Finance | SSale | −412 | $2.18 | −$898.16 | −1.6%24.6K after |